OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transferrin receptor 1 targeted nanomedicine for brain tumor therapy
Jianru Li, Zixia Zhang, Baoli Zhang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 10, pp. 3394-3413
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics
Harshita Tiwari, Nilesh Rai, Swati Singh, et al.
Bioengineering (2023) Vol. 10, Iss. 7, pp. 760-760
Open Access | Times Cited: 66

Construction Strategy of Functionalized Liposomes and Multidimensional Application
Chengyun Wang, Xinyue Lan, Longjiao Zhu, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 18

Nanozyme-based strategies for efficient theranostics of brain diseases
Ran Xu, Sijie Zhang, Peixia Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215519-215519
Closed Access | Times Cited: 32

Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
Paul S. Kawak, Nour M. Al Sawaftah, William G. Pitt, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13262-13262
Open Access | Times Cited: 15

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
Xiaochun Bian, Liping Zhou, Zhiwei Luo, et al.
ACS Nano (2025)
Closed Access

Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access

Design and application of ferritin-based nanomedicine for targeted cancer therapy
Baoli Zhang, Kelong Fan
Nanomedicine (2025), pp. 1-20
Closed Access

Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access

Advances in blood–brain barrier-crossing nanomedicine for anti-glioma
Dongdong Liu, Xingliang Dai, Zhenchao Tao, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13

Recent progress of nanomedicine in the treatment of Alzheimer’s disease
Liqiang Hu, Yiran Tao, Yanjiao Jiang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11

Research Progress on the Strategies for Crossing the Blood–Brain Barrier
Li Qiao, Xiuwei Du, Hua Wang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 10, pp. 4786-4803
Closed Access | Times Cited: 3

Ferritin-nanocaged aggregation-induced emission nanoaggregates for NIR-II fluorescence-guided noninvasive, controllable male contraception
Xinghua Yu, Jiaxue Shuai, Ge Meng, et al.
Materials Today Bio (2024) Vol. 25, pp. 100995-100995
Open Access | Times Cited: 2

The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy
Han Wu, Yumei Wang, Zekai Ren, et al.
Chinese Chemical Letters (2024), pp. 109996-109996
Closed Access | Times Cited: 2

Advancements in the application of nanotechnology for the management of epileptic seizures
Honglu Ping, Ding Ding, Guoxing Zhu, et al.
Acta Epileptologica (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2

Advances in active targeting of ligand-directed polymeric nanomicelles via exploiting overexpressed cellular receptors for precise nanomedicine
Mona M. Agwa, Rehab Elsayed Marzouk, Sally Sabra
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23520-23542
Open Access | Times Cited: 2

Advancements in strategies for overcoming the blood–brain barrier to deliver brain-targeted drugs
Zhichuang Qu, Juan Luo, Zheng Li, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2

A state-of-the-art liposome technology for glioblastoma treatment
Ikram Hasan, Shubham Roy, Ehexige Ehexige, et al.
Nanoscale (2023) Vol. 15, Iss. 45, pp. 18108-18138
Closed Access | Times Cited: 7

Rational Design of Pectin–Chitosan Polyelectrolyte Nanoparticles for Enhanced Temozolomide Delivery in Brain Tumor Therapy
V. E. Silant’ev, Andrei S. Belousov, Fedor O. Trukhin, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1393-1393
Open Access | Times Cited: 1

Surface Active Ligands for Enhanced Brain Targeting of Nanoparticles
A Prabakaran, Rajat Vashist, Sanchita Dhanchandra Sangave, et al.
(2024), pp. 241-262
Closed Access | Times Cited: 1

Controlled and Targeted Drug Delivery Using Smart Nanovectors
Abou Bakr M. Salama, Yasmin Salem, Tamer Mohamed
International Journal of Drug Discovery and Pharmacology (2023), pp. 84-90
Open Access | Times Cited: 2

Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: Towards development of non-invasive early detection strategies
Simon N. Mbugua
Dyes and Pigments (2023) Vol. 219, pp. 111603-111603
Closed Access | Times Cited: 2

Transferrin-modified carboxymethyl chitosan-chitosan nanoparticles as an efficient delivery carrier for targeted therapy of depression
Junhui He, Li Yang, Dongmei Li, et al.
International Journal of Biological Macromolecules (2024), pp. 138352-138352
Closed Access

Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access

Page 1 - Next Page

Scroll to top